Introduction
Papillary fibroelastomas (PFEs) are considered to be the most frequent primary cardiac tumors [1] . Most often they are unique masses in the left cardiac chambers with a propensity for valvular surfaces [2] . PFEs are associated with an increased risk of neurological events, either stroke or transient ischemic accident (TIA), while rarely being directly responsible for valve dysfunction [1] . There is evidence that they arise more often in patients with hypertrophic cardiomyopathy (HCM) [3] . From a historical perspective, a shift in their diagnosis has occurred, moving from an incidental intraoperative or autopsy discovery to ante-mortem diagnosis. This is largely due to the continuous improvement of imaging tools, such as better resolution of transthoracic echocardiography (TTE) [4] [5] [6] and a wider availability of transesophageal echocardiography (TEE) [7] , using both two-and three-dimensional techniques. The only treatment which has shown clear benefits is represented by careful surgical excision of all such tumors, with excellent results, with a low incidence of both valve replacements and recurrence [1, 8] .
Case report
We report the case of a 59-year-old woman diagnosed with hypertrophic obstructive cardiomyopathy (HOCM) at the age of 40, with irregular follow-up visits and episodes of persistent atrial fibrillation. She complained of shortness of breath related to moderate exercise and short
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The TTE revealed HOCM with increased septal thickness (16 mm) and a left ventricle outflow tract (LVOT) dynamic pressure gradient of 34 mmHg after Valsalva manoeuver, systolic anterior motion (SAM) of the anterior mitral leaflet (AML) for over 50% of systolic duration, left ventricular (LV) longitudinal dysfunction, moderate mitral regurgitation with a mixed mechanism (both degenerative and functional), with severe mitral annulus calcification, indirect signs of high pulmonary artery pressure, severe tricuspid regurgitation and severe biatrial enlargement. Additionally, TTE found several intracardiac masses (fig 1a,b) , described as mobile, round, homogenous, with well-defined borders, of different sizes and all under 10 mm. They were distributed throughout the structures of the left heart: near the postero-medial papillary muscle, in the LVOT at the point of contact between the interventricular septum (IVS) and the AML, and on the right coronary cusp of the aortic valve. Transesophageal echocardiography detected a supplementary small mass on the atrial side of the AML and multiple tumors were described on all aortic valve cusps (fig 1c,d) . The echocardiographic appearance and distribution raised the suspicion of PFEs. Coronary computed tomography angiogram showed hypoplastic right coronary artery and no atherosclerotic lesions.
Surgical excision was recommended but the patient suffered a stroke and cardiac surgery was realized 1 month after the stroke. Aortic valve replacement and excision of all the reported tumors were performed, including a mass near the LV apex, previously undetected by echocardiography. Histopatologic and immunhistochemical examinations (positive for CD34, S-100 protein, vimentin and type IV collagen) confirmed the diagnosis of PFEs (fig 2) . Postoperative evolution at 6 months was excellent. 
Discussions
The present case illustrates the ability, and also the shortcomings, of cardiac ultrasonography to reveal intracardiac masses, to suggest the specific etiology and to guide specific treatment.
PFEs are considered to be primary cardiac tumors, more than 95% arising in the left heart [2] and about 77% being located on the valvular surfaces (usually from the mid portion of the cusps). Their size can vary widely, from 1-2 mm to 70 mm [9] , but are usually around 10 mm [10] . A study which included 19 patients with PFEs and HOCM [3] found that, in this patient population, PFEs are more frequent (0.28% versus 0.02% in the overall population) and are more likely to occur on the aortic valve (47%) and along the LVOT (42%), as was the case of our patient. While rare and relatively small, PFEs can have devastating clinical consequences. Thromboembolic events in all arterial territories can be associated with left cardiac chambers PFEs [2] . Even though most often they are solitary lesions, in rare instances such as in the case of our patient, multiple PFEs can be present, so a thorough inspection of all cardiac chambers is mandatory.
On echocardiography, these tumors are usually small, with well-demarcated borders, with various shapes (round, oval or irregular), with a homogenous appearance, sometimes presenting with a "speckled" or a "stippling" perimeter. TEE, as compared to TTE, is a better technique for detecting and describing the extent and precise attachment of PFEs [1] , but sometimes direct inspection during surgery finds supplementary lesions, as was the case of our patient. Unfortunately, at the moment, there are no parameters that can be evaluated in order to classify PFEs into low-or high-risk according to their embolization potential. Tumor mobility, as assessed by echocardiogram, did not prove to be a reliable predictor of embolic events [1] . These abnormal structures can be partly responsible for valve insufficiency or hemodynamic conditions similar to stenosis or are simply superimposed on structures whose dysfunction has a distinctive etiology (e.g. degenerative, functional etc.) as was the case of our patient.
Usually, surgical shave-excision is a highly successful therapy [1, 8] . A recent study reported, for the first time, a recurrence rate of 1.6% [1] , with important implications concerning patient follow-up. Some of the prevailing theories are that PFEs could be wear-and-tear type lesions, occurring where turbulent flow affects the underlying endothelium, or that they can occur after cardiac surgery.
The particularities of the case consisted of the incidental finding of numerous PFEs with several valvular and nonvalvular localizations in a patient with HOCM, for which complex ultrasosnographic examination established an accurate diagnosis. In conclusion, the diagnosis of PFEs can be established using integrated echocardiography modalities (TTE, TEE, 3D echocardiography) and should be considered as a differential diagnosis when observing intracardiac masses in a patient with HOCM. Follow-up remains crucial in these patients due to the risk of recurrence.
